Verapamil

pubchem

Verapamil

Check on pubchem

drugmap

Verapamil

Check on drugmap

drugmap

Verapamil

Check on drugmap

drugmap

Verapamil

Check on drugmap

wiki

Verapamil

Check on wiki

SMILES:COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C2=CC(OC)=C(OC)C=C2)C(C)C)C=C1

InChI:InChI=1S/C27H38N2O4/c1-20(2)27(19-28,22-10-12-24(31-5)26(18-22)33-7)14-8-15-29(3)16-13-21-9-11-23(30-4)25(17-21)32-6/h9-12,17-18,20H,8,13-16H2,1-7H3

InChI key:SGTNSNPWRIOYBX-UHFFFAOYSA-N

Synonyms: Alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile, 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile, Alpha-Isopropyl-alpha-((N-methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile, Veracim, Verapamil (Na-Ca chanel blocker), Verapamil [USAN:INN:BAN], Cordilox, Verapamilo [INN-Spanish], Lekoptin, Verapramil, Dexverapamilo [INN-Spanish], Dexverapamilo, CHEBI:77734, Isotopin, (1)-3-(3,4-Dimethoxyphenyl)-6-((5,6-dimethoxyphenethyl)methylamino)hexane-3-carbonitrile, Dexverapamilum [INN-Latin], Verapamil (USAN/INN), Vasolan,Verapamil, Isoptine, Dexverapamil [INN], Alpha-((N-Methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile, UNII-QR5PYD126V, (+)-3-(3,4-Dimethoxyphenyl)-6-((5,6-dimethoxyphenethyl)methylamino)hexane-3-carbonitrile, 2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile, Veraptin, Verapamil, CP-16533-1, Isoptin SR, Dilacoran, Verapamilum,Arpamyl, C, Dexverapamilum, Calan (TN), Drosteakard, Verapamilum [INN-Latin], Verexamil, Verapamilo, Verapamil [USAN:BAN:INN], Iproveratril, Verpamil, Falicard, Covera-HS, 5-[(3,4-Dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile, 5-((3,4-Dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile, (+)-verapamil, Tarka, Finoptin, (+)-(R)-5-((3,4-Dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile, Verelan PM, Dexverapamil, 2-(3,4-Dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-(1-methylethyl) pentanenitrile, Verelan (TN),Dexverapamil, (R)-5-((3,4-dimethoxyphenethyl)(methyl)amino)-2-(3,4-dimethoxyphenyl)-2-isopropylpentanenitrile, QR5PYD126V, Calan,VERAPAMIL, Securon, (+-)-Verapamil, Isoptin (TN), CCRIS 6749, 52-53-9,5-[N-(3,4-Dimethoxyphenethyl)-N-(methyl)amino]-2-(3,4-dimethoxyphenyl)-2-iso-propyl-valero-nitrile, Covera-HS (TN), D-365, Verelan, (+/-)-VERAPAMIL, Calcan, verapamil-r, R(+)-VERAPAMIL, Bosoptin (TN), Izoptin, Isoptin, Isoptimo, 38321-02-7
Categories (non-exhaustive):

Similarities

Being able to identify molecules that are similar to the one we study can allow to infer some of its properties. There are several ways of measuring the similarity between molecules, by their structure, effects, pharmacological interactions etc. In the following, you can find similar molecules according to various criterions and tools that we developed. To understand the limitations of these comparisons, it is crucial to always refer to the methodology that was used to measure those similarities. Please note: This information is provided solely for informational purposes and should not be interpreted as medical advice.

To measure structural similarity, we use the Mol2vec method, which is a neural network that processes molecules and transform them into points in spaces, such that molecules with chemically related substructures are transformed into points that are close in space.

Molecule properties

Using the KGPT Deep Learning model, we predict several property of the molecule. Predictions are grouped by the dataset that was used to get those prediction. Along with each prediction, we provide a plot that shows the distribution of predicted values on the train/test/val dataset. This gives an estimate of the reliability of the model.

Description: A dataset focused on predicting the inhibitory effects of molecules on the enzyme beta-secretase 1 (BACE1). BACE1 inhibition is a potential target for Alzheimer's disease treatment.
Class
TrainValTest
2.88-3.70-1.36
Description: A dataset providing insights on the ability of molecules to penetrate the blood-brain barrier. Crucial for understanding the potential of molecules as central nervous system drugs.
p_np
TrainValTest
-2.24-3.290.40
Description: This dataset deals with the FDA approval status and clinical trial toxicity of molecules. Important for understanding the safety and regulatory status of compounds.
CT_TOX
TrainValTest
-0.49-0.78-0.91
FDA_APPROVED
TrainValTest
0.53-1.27-0.50
Description: A dataset that predicts the solubility of molecules in water. Solubility is an essential property influencing bioavailability and the potential formulation of a drug.
logSolubilitylog(mol/L)
-2.01
TrainValTest
Description: This dataset is centered on predicting the free energy when a molecule is dissolved in water. The energy changes can affect molecular interactions in biological systems.
freesolvkcal/mol
-0.99
TrainValTest
Description: A dataset predicting the lipophilicity of molecules. Lipophilicity is a crucial factor affecting the distribution, metabolism, and excretion of drugs in the body.
lipoAlogP
0.33
TrainValTest
Description: This dataset gives insights into the metabolic stability of molecules. High metabolic stability often results in a longer half-life, influencing drug dosage and frequency.
low
TrainValTest
-0.17-3.50-2.88
high
TrainValTest
0.72-3.55-0.49
27 entries
12 entries
617 entries

Advanced insights

In the following we provide more advanced analysis about the interactions of a molecule with the human metabolism, docking sites etc.

Interaction of this molecule with metabolism

We use a Deep Learning model to predict the interactions of this molecule with metabolism. Refer to the source to understand the methodology.

Reactions that metabolize this molecule
N-Glucuronidation of tertiary aliphatic amine BTMR0244
Enzymes: 2.4.1.17
Reagents

Metabolite: InChI=1S/C33H46...

Hydroxylation of non-terminal aliphatic carbon adjacent to aromatic ring BTMR1077
Reagents

Metabolite: InChI=1S/C27H38...

O-Dealkylation BTMR0052
Reagents

Metabolite: InChI=1S/C26H36...

O-Dealkylation BTMR0052
Reagents

Metabolite: InChI=1S/C26H36...

O-Dealkylation BTMR0052
Reagents

Metabolite: InChI=1S/C26H36...

O-Dealkylation BTMR0052
Reagents

Metabolite: InChI=1S/C26H36...

N-Oxidation of aliphatic tertiary amine BTMR1100
Enzymes: CYP1A2 CYP2D6 CYP3A4
Reagents

Metabolite: InChI=1S/C27H38...

Hydroxylation of terminal methyl BTMR1061
Reagents

Metabolite: InChI=1S/C27H38...

Terminal desaturation BTMR1190
Reagents

Metabolite: InChI=1S/C27H36...

N-Dealkylation of acyclic tertiary amine BTMR1142
Reagents

Metabolite: InChI=1S/C16H21...

N-Dealkylation of acyclic tertiary amine BTMR1142
Reagents
isomerdesign

N-Methylhomoveratrylamine

N-Dealkylation of acyclic tertiary amine BTMR1142
Reagents

InChI=1S/C17H26N2O2/...

N-Dealkylation of acyclic tertiary amine BTMR1142
Reagents

InChI=1S/C10H12O3/c1...

N-Dealkylation of acyclic tertiary amine BTMR1142
Reagents
drugmap

Arverapamil

Hydroxylation of penultimate aliphatic tertiary carbon BTMR1075
Reagents

Metabolite: InChI=1S/C27H38...

Aliphatic hydroxylation of carbon alpha to secondary or tertiary alkyl-N BTMR1081
Reagents

Metabolite: InChI=1S/C27H38...

Aliphatic hydroxylation of carbon alpha to secondary or tertiary alkyl-N BTMR1081
Reagents

Metabolite: InChI=1S/C27H38...

Degradation of aliphatic nitrile to carboxylic acid BTMR1258
Enzymes: 3.5.5.7
Reagents

Metabolite: InChI=1S/C27H39...